LINDA AG launches first OTC private-label medicine with ibuprofen
LINDA AG is introducing Ibuprofen 400 mg as the first OTC medicine under its own pharmacy brand across LINDA Premium pharmacies.
Image modified: LINDA AG
Novo Nordisk sues Eli Lilly over GLP-1 advertising
Novo Nordisk has sued Eli Lilly in the US over GLP-1 campaigns for Zepbound and Mounjaro, alleging misleading comparative ads.
Mediengruppe DAV reorganizes management board
Mediengruppe Deutscher Apotheker Verlag is reorganizing its management board in response to changes in its market environment.
Convatec CFO Fiona Ryder to step down, Tobias Hestler joins board
Convatec is preparing a CFO change. Fiona Ryder will remain until a successor is appointed, while Tobias Hestler joins the board.
Sanofi reshapes Executive Committee
Sanofi will reshape its Executive Committee on September 1, 2026, with changes across R&D, business units, finance and regional roles.
Tarsus names Neera Clase interim Chief Commercial Officer
Tarsus Pharmaceuticals says CCO Aziz Mottiwala will depart, with Neera Clase taking over the commercial role on an interim basis.
Thieme launches digital practice platform for physicians
Thieme is launching Thieme Praxis, a digital platform and app for medical information, CME content and tools in physicians’ daily work.
Lilly to acquire AtaiBeckley and expand depression pipeline
Lilly plans to acquire AtaiBeckley, adding clinical neuroplastogen programs for treatment-resistant depression to its neuroscience pipeline.
Novartis, Klinikum Bayreuth and myon.clinic launch digital RLT network
Novartis, Klinikum Bayreuth and myon.clinic are piloting a digital patient pathway for radioligand therapy in prostate cancer care.
Schwabe takes majority stake in Hydraid
Schwabe Group takes a majority stake in Hydraid, strengthening its position in natural health solutions and functional sports hydration.